BIOATLA INC (BCAB)
US09077B1044 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.2M -51.08% | 430K -91.73% | 250K -41.86% | 1.53M -100.00% | 11.22M | -100.00% | 25.493M | 51.664M 102.66% | 82.199M 59.10% | 119.97M 45.95% | 166.08M 38.43% | |||
| EBITDA YoY % growth | -27.41M 0.11% | -29.09M -6.13% | -95.11M -226.95% | -112.751M -12.44% | -139.74M -20.13% | -98.94M 22.98% | -112.2M -13.40% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -28.27M -0.14% | -30.1M -6.47% | -96.44M -220.40% | -112.063M -12.13% | -139.42M -19.93% | -79.445M 38.74% | -98.015M -23.37% | -117.275M -19.65% | -135.284M -15.36% | -91.912M 32.06% | -73.462M 20.07% | -53.846M 26.70% | -25.543M 52.56% | |
| Operating Margin | -543.65% | -7,000.00% | -38,576.00% | -7,324.40% | N/A | -708.07% | N/A | N/A | -530.67% | -177.90% | -89.37% | -44.88% | -15.38% | |
| EPS YoY % growth | N/A | N/A | -2.76 -115.52% | -2.87 0.72% | -2.82 5.47% | -1.55 40.27% | -1.34 13.63% | -1.36 -1.78% | -1.30 4.37% | -0.87 32.94% | -0.74 14.62% | -0.64 14.38% | -0.51 20.00% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 30.79% | -0.37 23.50% | -0.35 21.18% | -0.36 -64.59% | -0.41 -5.26% |
| Revenue Q2Q % growth | -100.00% | ||||
| EBITDA Q2Q % growth | -22.44M 17.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.592M 27.84% | -25.775M -5.39% | -28.485M -29.64% | -31.208M -176.91% | -33.945M -64.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.22 68.57% | -0.37 | 0.15 | 40.09% |
| Q2 2024 Q2Q % growth | -0.44 41.33% | -0.45 | 0.01 | 1.51% |
| Q1 2024 Q2Q % growth | -0.48 17.24% | -0.55 | 0.07 | 13.18% |
| Q4 2023 Q2Q % growth | -0.56 11.11% | -0.81 | 0.25 | 30.72% |
| Q3 2023 Q2Q % growth | -0.70 -1.45% | -0.82 | 0.12 | 14.22% |
| Q2 2023 Q2Q % growth | -0.75 2.60% | -0.65 | -0.10 | -14.89% |
| Q1 2023 Q2Q % growth | -0.58 10.77% | -0.64 | 0.06 | 9.45% |
| Q4 2022 Q2Q % growth | -0.63 -1.61% | -0.71 | 0.08 | 11.44% |
| Q3 2022 Q2Q % growth | -0.69 -1.47% | -0.82 | 0.13 | 15.49% |
| Q2 2022 Q2Q % growth | -0.77 14.44% | -0.70 | -0.07 | -10.10% |
| Q1 2022 Q2Q % growth | -0.65 -16.07% | -0.68 | 0.03 | 4.86% |
| Q4 2021 Q2Q % growth | -0.62 58.67% | -0.64 | 0.02 | 3.15% |
| Q3 2021 Q2Q % growth | -0.68 | -0.66 | -0.02 | -3.58% |
| Q2 2021 Q2Q % growth | -0.90 | -0.60 | -0.30 | -50.88% |
| Q1 2021 Q2Q % growth | -0.56 | -0.53 | -0.03 | -4.98% |
| Q4 2020 Q2Q % growth | -1.50 | -0.79 | -0.71 | -88.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 1.53M | -1.53M | -100.00% | |
| Q3 2022 Q2Q % growth | 476.003K | -476.003K | -100.00% | |
| Q2 2022 Q2Q % growth | -100.00% | 408K | -408K | -100.00% |
| Q1 2022 Q2Q % growth | 382.5K | -382.5K | -100.00% | |
| Q4 2021 Q2Q % growth | 4.692M | -4.692M | -100.00% | |
| Q3 2021 Q2Q % growth | -100.00% | 11.22M | -11.22M | -100.00% |
| Q2 2021 Q2Q % growth | 250K 31.58% | 250K | % | |
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | 150K -95.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.26% | 0% | 2.53% |
| Revenue | N/A | N/A | 0% | N/A |